COVID-19 Infection | Norton Healthcare

Indication: COVID-19 Infection

Convalescent Plasma in the Early Treatment of High-Risk Patients with SARS-CoV-2 (COVID-19) Infection

High-Risk

Drug Study

Principal Investigator: Joseph Flynn, Physician-in-Chief NCI
Norton Cancer Institute

Sponsor: NH Investigator

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.